The money will be used for scaling on the Western markets and for the development of new algorithms that can analyze all body areas in medical imaging, not just lungs, as at the moment.
In about six years, Rayscape has attracted EUR2 million investments and in 2024 had annual recurring revenue of almost EUR1 million, 30% of which from abroad.
(English version by Loredana Fratila-Cristescu)